Indirect Bilirubin

Indirect bilirubin is a biomarker used in liver-related assessment. Also known as IBIL, it is one laboratory measure considered among liver biomarkers when reviewing results.

Indirect Bilirubin is assessed using a serum sample, collected through a blood test. Fasting is not required for this measurement, so the test can generally be arranged without fasting-specific preparation.

When reviewing the result, the related markers Bilirubin Total and Bilirubin Direct may also be considered. Looking at these measurements together can provide broader context than considering indirect bilirubin alone, particularly when a clinician is assessing bilirubin-related findings.

The result is reported in mg/dL and should be interpreted using the reference and optimal ranges shown with the test. Individual results may need to be reviewed alongside the reason for testing and other clinical information. A clinician can explain what the result means in the context of a person’s symptoms, health history, and any other laboratory findings.

Interpret the result against the reference range printed on the laboratory report. A value inside that interval is within the laboratory’s reference range, while the optimal range is a narrower interval intended to represent a more specific target. Being outside the optimal range does not automatically mean that something is wrong, particularly when the result remains within the reference range.

Laboratories may use different reference ranges or units, so a number is meaningful only alongside the range and units shown on the same report. This measurement uses a serum sample, and fasting is not required according to the listed testing information.

A single value is not a diagnosis. Results are interpreted in context, including the reason for testing and other clinical information. An out-of-range result should be discussed with a clinician, who can determine whether follow-up or further evaluation is appropriate.